Neurological disorder

Chronic Inflammatory Demyelinating Polyneuropathy Market to Register Positive Growth During the Study Period (2019-2032), Evaluates DelveInsight | Key Companies to Watch Out - Octapharma, argenx, Immunovant Sciences, Sanofi, Janssen, Takeda

Retrieved on: 
Tuesday, December 12, 2023

LAS VEGAS, Dec. 12, 2023 /PRNewswire/ -- DelveInsight's Chronic Inflammatory Demyelinating Polyneuropathy Market Insights report includes a comprehensive understanding of current treatment practices, chronic inflammatory demyelinating polyneuropathy emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan].

Key Points: 
  • As per DelveInsight estimates, CIDP in the US showed that males account for the highest number of cases as compared to females in 2022.
  • The promising chronic inflammatory demyelinating polyneuropathy therapies in the pipeline include Panzyga, Efgartigimod, Batoclimab, SAR445088, Nipocalimab, and others.
  • Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare neurological disorder that causes progressive weakness and reduced sensation in the arms and legs.
  • CIDP shows itself through symmetrical weakness in the hands, feet, hips, and shoulders, gradually worsening over a minimum of two months.

Nexus Children's Hospital - Shenandoah Responds to Critical Need for Behavioral Care

Retrieved on: 
Monday, December 11, 2023

THE WOODLANDS, Texas, Dec. 11, 2023 /PRNewswire/ -- Nexus Health Systems is partnering with local pediatric hospitals to address the 800% rise in emergency room visits seen by Texas Children's Hospital from young people with severe mental illness. Admitting ages 13 to 30, Nexus Children's Hospital – Shenandoah is equipped to treat higher acuity patients with co-occurring medical and behavioral diagnoses. Its integrated treatment approach is uniquely suited to meet the growing demand for complex care in the Houston area.

Key Points: 
  • Admitting ages 13 to 30, Nexus Children's Hospital – Shenandoah is equipped to treat higher acuity patients with co-occurring medical and behavioral diagnoses.
  • Nexus' integrated approach is uniquely suited to meet the growing demand for complex care in the Houston area.
  • Combining psychiatry, pediatrics, physical medicine, neurology, and formal rehabilitative therapies, Nexus offers comprehensive care in one home-like setting, hospital CEO James Resendez said.
  • The hospital will offer three programs:
    The people Nexus serves need help navigating life — they may be lost in the system or struggling with medical and behavioral health challenges.

Rocket Science Health to Present Data Related to Its In-Development Targeted Intranasal Drug Device at Boston CNS Summit

Retrieved on: 
Wednesday, December 6, 2023

Currently, about 95 per cent of small molecule and nearly all large molecule drug therapies approved by the FDA cannot cross the blood brain barrier.

Key Points: 
  • Currently, about 95 per cent of small molecule and nearly all large molecule drug therapies approved by the FDA cannot cross the blood brain barrier.
  • A breakthrough in delivery of drugs to the brain would be significant for the treatment of many central nervous system (CNS) disorders.
  • Rocket Science Health also announced the appointments of two seasoned experts to support the growing company: Sohier Hall, as President; and Dr. Jacob Hooker, as Chief Science Advisor.
  • Rocket Science Health, founded by business leader Kenneth Irving, is a private, B.C.-based healthcare technology company that is revolutionising direct to brain drug delivery.

Transposon Announces Interim Results from a Phase 2 Study of TPN-101 for the Treatment of Progressive Supranuclear Palsy to be Presented at the AD/PD™ 2024 International Conference on Alzheimer's and Parkinson's Diseases

Retrieved on: 
Tuesday, November 14, 2023

SAN DIEGO, Nov. 14, 2023 /PRNewswire/ -- Transposon Therapeutics, a biotechnology company developing a platform of novel, orally administered therapies for the treatment of neurodegenerative and aging-related diseases, today announced its abstract of interim results from its Phase 2 study of TPN-101 for the treatment of progressive supranuclear palsy (PSP) has been accepted for poster presentation at the hybrid AD/PD™ 2024: 18th International Conference on Alzheimer's and Parkinson's Diseases. The meeting will take place online and in Lisbon, Portugal, from March 5-9, 2024.

Key Points: 
  • In the treatment group receiving 400 mg of TPN-101 once daily for 24 weeks, TPN-101 showed an 18.4% reduction in NfL levels in CSF as compared to placebo.
  • "The lowering of CSF NfL levels seen in this interim analysis provides biomarker evidence of a treatment effect on neurodegeneration.
  • We are excited about the potential of TPN-101 as a much-needed treatment option for patients with PSP.
  • Transposon will present results from the interim analysis in a poster presentation (abstract #433) at AD/PD 2024 entitled: "A Phase 2a Study of TPN-101, a Nucleoside Reverse Transcriptase Inhibitor, in Patients with Progressive Supranuclear Palsy."

Blink Communicate Emerges as a Desktop App, Empowering Locked-In Syndrome Patients to Communicate Through Blinks

Retrieved on: 
Thursday, November 9, 2023

Seattle, Washington--(Newsfile Corp. - November 9, 2023) - To address the latest innovation, Blink Communicate unleashes a desktop app that empowers locked-in syndrome patients to communicate through blinks. The application leverages the power of AI and Computer Vision technologies to enable communication through eye blinks.

Key Points: 
  • Summary: Blink Communicate, a well-established platform in the realm of assistive technology, has introduced its revolutionary desktop application aimed to transform the lives of Locked-In Syndrome patients.
  • Seattle, Washington--(Newsfile Corp. - November 9, 2023) - To address the latest innovation, Blink Communicate unleashes a desktop app that empowers locked-in syndrome patients to communicate through blinks.
  • The application leverages the power of AI and Computer Vision technologies to enable communication through eye blinks.
  • This innovation ensures that Locked-In Syndrome patients can convey their thoughts, emotions, and needs with ease and precision.

Fluoride: very high levels in water associated with cognitive impairment in children

Retrieved on: 
Tuesday, November 7, 2023

It suggests a link between high fluoride levels in water and cognitive impairment in children.

Key Points: 
  • It suggests a link between high fluoride levels in water and cognitive impairment in children.
  • The study, published in the journal Neurotoxicology and Teratology, was based on 74 children in Ethiopia who were exposed to high fluoride in drinking water – averaging 7.6 milligrams per litre.
  • This latest study found that children drinking water with high levels of fluoride performed worse in tests designed to evaluate new learning and memory.
  • The recent paper did not find a strong association between high fluoride in drinking water and the mental abilities of children aged five to 14 years.

HARMONY BIOSCIENCES SHOWCASES THE NEWEST PATIENTS AT THE HEART AND PROGRESS AT THE HEART AWARD RECIPIENTS

Retrieved on: 
Thursday, October 26, 2023

"With support from a previous Patients at the Heart award, we achieved the 'Strategic Communications for Awareness' project, which fortified and expanded our patient registry and outreach endeavors.

Key Points: 
  • "With support from a previous Patients at the Heart award, we achieved the 'Strategic Communications for Awareness' project, which fortified and expanded our patient registry and outreach endeavors.
  • Progress at the Heart provides funding support for novel initiatives addressing disparities, injustices, and inequities in rare neurological disease and sleep disorder communities.
  • The next call for Patients at the Heart and Progress at the Heart award nominations will be announced next year.
  • To learn more about Patients at the Heart, please visit: https://www.harmonybiosciences.com/funding-programs/patients-at-the-heart/ .

Nexus Children's Hospital - Dallas Announces Grand Opening

Retrieved on: 
Wednesday, September 27, 2023

DALLAS, Sept. 27, 2023 /PRNewswire/ -- Nexus Health Systems, a network of inpatient specialty care hospitals and residential campuses, announced today the grand opening of its Dallas location. The new hospital will care for infants, children, adolescents and young adults with debilitating injuries and conditions, such as brain or spinal cord injury, neurodevelopmental delays and autism, as well as other complex diagnoses.

Key Points: 
  • DALLAS, Sept. 27, 2023 /PRNewswire/ -- Nexus Health Systems , a network of inpatient specialty care hospitals and residential campuses, announced today the grand opening of its Dallas location.
  • As a true partner to the already impressive Dallas healthcare scene, the Nexus Children's Hospital model is a necessary newcomer.
  • Nexus Children's Hospital – Dallas has 60 private inpatient rooms in addition to a variety of amenities across 80,000+ square feet.
  • Nexus Children's Hospital truly is the best option for post-acute care in Dallas, Director of Business Development Tanisha Herrod added.

Is it normal to forget words while speaking? And when can it spell a problem?

Retrieved on: 
Monday, September 25, 2023

Why does this universal problem among speakers happen?

Key Points: 
  • Why does this universal problem among speakers happen?
  • Everyone will experience an occasional word-finding difficulty, but if they happen very often with a broad range of words, names and numbers, this could be a sign of a neurological disorder.

The steps involved in speaking


    Producing spoken words involves several stages of processing. These include:
    • When a healthy speaker can’t retrieve a word from their lexicon despite the feeling of knowing it, this is called a “tip-of-the-tongue” phenomenon by language scientists.
    • Tip-of-the-tongue states are relatively common and are a type of speech error that occurs primarily during retrieval of the sound pattern of a word (step three above).

What can affect word finding?

    • In older adults, they can cause frustration and anxiety about the possibility of developing dementia.
    • One way researchers investigate word-finding difficulties is to ask people to keep a diary to record how often and in what context they occur.
    • It’s thought this is because they have weaker connections between their meanings and their sound patterns than more frequently used words.

When could it spell more serious issues?

    • More frequent failures with a broader range of words, names and numbers are likely to indicate more serious issues.
    • Primary progressive aphasia is typically associated with frontotemporal or Alzheimer’s dementias, although it can be associated with other pathologies.
    • An assessment by a clinical neuropsychologist or speech pathologist can help clarify which processing stage is affected and how serious the problem might be.
    • They might also be provided with a cue or prompt, such as the first letter (h) or syllable (ham).
    • This is typically a sign of a more serious issue such as primary progressive aphasia.

FAU RECEIVES $750,000 PHILANTHROPIC GRANT FOR ALZHEIMER'S DISEASE

Retrieved on: 
Tuesday, September 19, 2023

BOCA RATON, Fla., Sept. 19, 2023 /PRNewswire/ -- More than 720,000 Floridians will be living with Alzheimer's disease by 2025. Currently, Florida has the second highest prevalence of Alzheimer's disease in the United States and is the sixth leading cause of death in Floridians 65 and older.

Key Points: 
  • BOCA RATON, Fla., Sept. 19, 2023 /PRNewswire/ -- More than 720,000 Floridians will be living with Alzheimer's disease by 2025.
  • Currently, Florida has the second highest prevalence of Alzheimer's disease in the United States and is the sixth leading cause of death in Floridians 65 and older.
  • This generous grant from the Carl Angus DeSantis Foundation will help our physicians and scientists combat a neurological disorder that currently impacts nearly 55 million people worldwide."
  • The Marcus Institute of Integrative Health at FAU Medicine combines a variety of evidence-based clinical services with the goal of meeting patients' health care needs.